domestic needs, falling behind on commitments to the COVAX partnership as well as on bilateral commercial deals with many countries," and Emergent BioSolutions' CEO "revealed that more than 100 million doses of Johnson & Johnson's vaccine were now on hold as regulators checked them for possible contaminatio